0001656695-21-000001.txt : 20211028 0001656695-21-000001.hdr.sgml : 20211028 20211028100813 ACCESSION NUMBER: 0001656695-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211028 DATE AS OF CHANGE: 20211028 EFFECTIVENESS DATE: 20211028 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Resonant Therapeutics, Inc. CENTRAL INDEX KEY: 0001656695 IRS NUMBER: 465197601 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-418881 FILM NUMBER: 211355707 BUSINESS ADDRESS: STREET 1: 1349B EAST VALLEY ROAD CITY: SANTA BARBARA STATE: CA ZIP: 93108 BUSINESS PHONE: 925.389.8539 MAIL ADDRESS: STREET 1: 1349B EAST VALLEY ROAD CITY: SANTA BARBARA STATE: CA ZIP: 93108 D 1 primary_doc.xml X0708 D LIVE 0001656695 Resonant Therapeutics, Inc. 2450 Holcombe Blvd. Suite J Houston TX TEXAS 77021 925.389.8539 DELAWARE None None Corporation true John K. Westwick 259 Butterfly Lane Santa Barbara CA CALIFORNIA 93108 Executive Officer Director Dan Watkins One Greenway Plaza Suite 930 Houston TX TEXAS 77046 Director Biotechnology Decline to Disclose 06b false 2021-10-15 false true false 0 4075997 2540901 1535096 false 16 0 0 0 false Resonant Therapeutics, Inc. John K. Westwick John K. Westwick Chief Executive Officer 2021-10-28